ArticleTrials2024

Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients.

Lea Dousset et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.